Celcuity, Inc. $CELC Stock Sold by Jefferies Financial Group Inc.

Jefferies Financial Group Inc. lowered its stake in Celcuity, Inc. (NASDAQ:CELC – Free Report) by 93.1% in the 3rd quarter, according to its most recent disclosure with the SEC. The fund owned 6,165 shares of the company’s stock after selling 83,069 shares during the quarter. Jefferies Financial Group Inc.’s holdings in Celcuity were worth $490,000 at the end of the most recent quarter.

A number of other institutional investors have also recently made changes to their positions in CELC. Pictet Asset Management Holding SA grew its holdings in shares of Celcuity by 10,659.7% in the third quarter. Pictet Asset Management Holding SA now owns 291,049 shares of the company’s stock worth $23,144,000 after purchasing an additional 288,344 shares during the last quarter. Integrity Alliance LLC. increased its stake in shares of Celcuity by 2.2% in the third quarter. Integrity Alliance LLC. now owns 11,868 shares of the company’s stock worth $944,000 after buying an additional 250 shares during the period. Profund Advisors LLC increased its stake in shares of Celcuity by 14.2% in the third quarter. Profund Advisors LLC now owns 18,292 shares of the company’s stock worth $1,455,000 after buying an additional 2,280 shares during the period. State of Wyoming purchased a new position in shares of Celcuity in the third quarter worth $251,000. Finally, China Universal Asset Management Co. Ltd. bought a new stake in Celcuity during the 3rd quarter valued at $105,000. Hedge funds and other institutional investors own 63.33% of the company’s stock.

Celcuity Stock Performance

CELC opened at $64.37 on Monday. The business has a 50 day simple moving average of $72.47 and a two-hundred day simple moving average of $98.23. The firm has a market capitalization of $3.16 billion, a price-to-earnings ratio of -13.67 and a beta of 0.16. The company has a debt-to-equity ratio of 6.04, a current ratio of 14.62 and a quick ratio of 14.59. Celcuity, Inc. has a one year low of $53.54 and a one year high of $151.02.

Celcuity (NASDAQ:CELC – Get Free Report) last released its quarterly earnings data on Thursday, November 5th. The company reported ($1.21) earnings per share for the quarter, topping the consensus estimate of ($1.51) by $0.30. Analysts predict that Celcuity, Inc. will post -5.01 EPS for the current year.

Wall Street Analyst Weigh In

CELC has been the subject of a number of recent analyst reports. Royal Bank Of Canada lowered shares of Celcuity to a “neutral” rating in a report on Wednesday, October 28th. TD Cowen reissued a “buy” rating and issued a $145.00 price target on shares of Celcuity in a report on Wednesday, October 21st. Zacks Research lowered shares of Celcuity from a “hold” rating to a “strong sell” rating in a report on Tuesday, October 13th. Weiss Ratings restated a “sell (d-)” rating on shares of Celcuity in a research report on Tuesday, September 1st. Finally, Stifel Nicolaus decreased their price objective on shares of Celcuity from $175.00 to $150.00 and set a “buy” rating on the stock in a research report on Friday, August 14th. Thirteen analysts have rated the stock with a Buy rating, one has assigned a Hold rating and two have issued a Sell rating to the stock. Based on data from MarketBeat, the company currently has an average rating of “Moderate Buy” and an average price target of $151.79.

Get Our Latest Research Report on Celcuity

About Celcuity

(Free Report)

Celcuity is a clinical-stage biotechnology company focused on developing targeted cancer therapies. The company uses its CELsignia platform to analyze signaling activity in tumor cells and identify patients who may be more likely to respond to treatments aimed at specific cellular pathways. Its drug-development program includes gedatolisib, a therapy designed to inhibit PI3K and mTOR signaling pathways. Celcuity is studying the drug in clinical trials for breast cancer and other solid tumors, with a focus on treatment strategies tailored to tumor biology.

See Also

Want to see what other hedge funds are holding CELC? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Celcuity, Inc. (NASDAQ:CELC – Free Report).

Institutional Ownership by Quarter for Celcuity (NASDAQ:CELC)

Receive News & Ratings for Celcuity Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Celcuity and related companies with MarketBeat.com's FREE daily email newsletter.